Panacur Bolus 12 g, Continuous Release Intraruminal Device

Country: United Kingdom

Language: English

Source: VMD (Veterinary Medicines Directorate)

Buy It Now

Active ingredient:

Fenbendazole

Available from:

MSD Animal Health UK Limited

ATC code:

QP52AC13

INN (International Name):

Fenbendazole

Pharmaceutical form:

Continuous-release intraruminal device

Prescription type:

POM-VPS -Prescription Only Medicine – Veterinarian, Pharmacist, Suitably Qualified Person

Therapeutic group:

Cattle

Therapeutic area:

Anthelmintic

Authorization status:

Authorized

Authorization date:

1995-12-01

Summary of Product characteristics

                                Revised: December 2020
AN: 01394/2020
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Panacur Bolus 12 g, Continuous Release Intraruminal Device
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Active substances
Each 12 g intraruminal device contains:
Qualitative composition
Quantitative composition in g
Fenbendazole
12
Excipients
For full list of excipients, see section 6.1
3.
PHARMACEUTICAL FORM
Continuous Release Intraruminal Device.
A cylindrical intraruminal device, consisting of 10 grey/black
flat-faced
intraruminal devices in a magnesium alloy tube, enclosed by plastic
rings.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cattle
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
The intraruminal device treats and prophylactically controls
gastrointestinal
nematode infections in cattle caused by _Ostertagia _spp.,
_Trichostrongylus _
spp., _Haemonchus _spp., _Cooperia _spp and _Oesophagostomum _spp. The
intraruminal device aids in the control of parasitic bronchitis caused
by
_Dictyocaulus viviparus._
For use in ruminating cattle in their first grazing season weighing
between
100kg and 300kg on the day of administration. When administered at
turnout,
the intraruminal device controls parasitic gastroenteritis throughout
the
grazing season by reducing the build up of infective larvae on the
pasture.
Reduced pasture contamination in the autumn lowers the risk of
inhibited
_Ostertagia_ larvae accumulating in sufficient numbers to cause winter
ostertagiasis. When administered later in the season, the intraruminal
device
is effective in the treatment of established parasitic infections and
continues to
Revised: December 2020
AN: 01394/2020
Page 2 of 6
have a prophylactic effect up to 140 days after administration. This
period
may be reduced if cattle are moved to heavily infected pasture.
4.3
CONTRA-INDICATIONS
Do not use in pre-ruminating cattle, cattle weighing less than 100kg
or cattle
less than 3 months of age.
Do not administer to cattle over 300kg.
4.4
SPECIAL WARNING F
                                
                                Read the complete document
                                
                            

Search alerts related to this product